SlideShare a Scribd company logo
CNS STIMULANTS
&
COGNITION
ENHANCERS
By-VIKAS AAGRAHARI
PHARM-D 2nd yr
DEPARTMENT OF PHARMACY
CNS
Stimulants
• Two groups of drugs that act primarily to stimulate the
central nervous system (CNS).
 Psychomotor stimulants
◦ Cause excitement and euphoria.
◦ Decrease feeling of fatigue.
◦ Increase motor activity.
 Hallucinogens (psychotomimetic drugs)
◦ Produce changes in thought patterns and mood.
• ◦ Amphetamine
• ◦ Dextroamphetamine
• ◦ Methylphenidate
• ◦ Caffeine
• ◦ Methylxanthines
• ◦ Nicotine
• ◦ Cocaine
Psychomotor stimulants
• ◦ Lysergic acid diethylamide (LSD)
• ◦ Tetrahydrocannabinol
• ◦ Phencyclidine
Hallucinogens
Cocaine
• Cocaine is a widely available and highly addictive drug that is currently abused daily by
more than 3 million people in the US.
 MOA:
• Causes blocking of reuptake of monoamines neurotransmitters. So, prolongs their
action.
 Actions:
• CNS: The behavioral effects of cocaine result from powerful stimulation of the
cortex and brainstem. Increases mental awareness and produces a feeling of well-
being and euphoria. Produce hallucinations and delusions of paranoia Respiratory
and vasomotor depression.
• Sympathetic nervous system: cocaine potentiates the action of norepinephrine.
• Hyperthermia.
Cocaine
Uses
• Cocaine has a local anesthetic action. For example, cocaine is
applied topically as a local anesthetic during eye, ear, nose,
and throat surgery. [Note: Cocaine is the only local anesthetic
that causes vasoconstriction.]
 Pharmacokinetic
• Self-administered by chewing, intranasal snorting, smoking,
or intravenous (IV) injection. The peak effect occurs at 15 to
20 minutes after intranasal intake of cocaine powder.
• Because the onset of action is most rapid, the potential for
overdosage and dependence is greatest with IV injection and
crack smoking.
• Cocaine is rapidly de-esterified and demethylated to
benzoylecgonine, which is excreted in the urine. Detection of
this substance in the urine identifies a user.
Cocaine
 Adverse effects:
• Anxiety
• Depression
• Toxic effects: Cocaine can induce
seizures as well as fatal cardiac
arrhythmias.
Methylxanthines
Include theophylline (tea); theobromine (cocoa); and caffeine (coffee, tea,
cocoa, chocolates, cola drinks).
Mechanism of action.
• Translocation of extracellular calcium.
• Increase in cAMP and cGMP caused by inhibition of phosphodiesterase.
• Blockade of adenosine receptors.
Methylxanthines
Actions
 CNS-
• Reduces fatigue ad increase mental alertness due to
stimulation of the cortex and other areas of the
brain.
• At very high doses, can produce anxiety and tremor.
• Tolerance to caffeine can develop and withdrawal
consists of feelings of fatigue and sedation.
 Cardiovascular system:
• At high doses, has positive inotropic and
chronotropic effects, can be harmful to angina
patients and can trigger premature ventricular
contractions.
 Diuretic action:
• Caffeine has a mild diuretic effect increasing urinary
output of Na, K, and Cl.
 Gastric mucosa:
• Stimulate secretion of hydrochloric acid from gastric
mucosa, should be avoided in peptic ulcer.
Methylxanthines
Therapeutic uses
• All methylxanthines relax the smooth
muscles and Causes relaxation of
bronchioles so use in supportive treatment
of Asthma.
Adverse effects
• Low dose causes insomnia, anxiety, and
agitation.
• A high dosage is required for toxicity, which
is manifested by emesis and convulsions.
• The lethal dose is about 10 g of caffeine
(about 100 cups of coffee), which induces
cardiac arrhythmias; death from caffeine is
thus highly unlikely.
Nicotine
 Nicotine is the active ingredient in tobacco. Although this drug
is not currently used therapeutically (except in smoking
cessation therapy), nicotine remains important because it is
second only to caffeine as the most widely used CNS
stimulant, and it is second only to alcohol as the most abused
drug. In combination with the tars and carbon monoxide
found in cigarette smoke, nicotine represents a serious risk
factor for lung and cardiovascular disease, various cancers,
and other illnesses. Dependency on the drug is not easily
overcome.
Mechanism of action:
• In low doses, nicotine causes ganglionic stimulation by
depolarization. At high doses, nicotine causes ganglionic
blockade. Nicotine receptors exist at a number of sites in
the CNS, which participate in the stimulant attributes of
the drug.
Nicotine
CNS stimulant.
Stimulation of sympathetic ganglia increases blood pressure and heart
rate.
Particularly harmful in hypertensive patients.
Nicotine induced vasoconstriction can decrease coronary blood flow,
adversely affecting a patient with angina.
High doses of nicotine result in central respiratory paralysis and severe
hypotension caused by medullary paralysis.
Along with other components of cigarettes like tars and carbon
monoxide, nicotine is a risk factor for lung and cardiovascular diseases
and cancer.
Nicotine
Causes dependence that is not easily overcome
Withdrawal symptoms include irritability, anxiety,
restlessness, headaches and insomnia
Smoking cessation programs should combine
pharmacologic and behavioral therapy
Transdermal nicotine patch and nicotine chewing
gum can reduce withdrawal symptoms
Bupropion (Wellbutrin®,
Zyban®)
Antidepressant, can reduce
the craving for cigarettes
Nicotine
• Because nicotine is highly lipid soluble, absorption
readily occurs
• Nicotine crosses the placental membrane and is
secreted in the milk of lactating women.
• The acute lethal dose is 60 mg. More than 90 percent
of the nicotine inhaled in smoke is absorbed.
• Clearance of nicotine involves metabolism in the lung
and the liver and urinary excretion.
Pharmacokinetic
• Irritability and tremors, intestinal cramps, diarrhea,
and increased heart rate and blood pressure.
• In addition, cigarette smoking increases the rate of
metabolism for a number of drugs
Adverse effects
Amphetamine
 Amphetamine is a non catecholaminergic sympathetic amine. Dextroamphetamine is the major member of this class of
compounds. Methamphetamine is a derivative of amphetamine that can be smoked, and it is preferred by many
abusers.
 MOA
• Releasing intracellular stores of catecholamines.
• Because amphetamine also inhibits monoamine oxidase (MAO), high levels of catecholamines are readily released
into synaptic spaces.
 Action
 CNS: Stimulates the entire cerebrospinal axis, cortex, brainstem, and medulla. This leads to increased alertness,
decreased fatigue, depressed appetite, and insomnia.
 Sympathetic nervous system: Amphetamine acts on the adrenergic system, indirectly stimulating the receptors
through norepinephrine release.
Amphetamine
 Uses
• Attention deficit hyperactivity disorder (ADHD): Some young
children are hyperkinetic and lack the ability to be involved in
any one activity for longer than a few minutes.
Dextroamphetamine and Methamphetamine are able to improve
attention and to alleviate many of the behavioral problems
associated with this syndrome
• Narcolepsy: [Narcolepsy is a relatively rare sleep disorder that is
characterized by uncontrollable bouts of sleepiness during the
day]. It is sometimes accompanied by catalepsy, a loss in muscle
control, or even paralysis brought on by strong emotions, such as
laughter. However, it is the sleepiness for which the patient is
usually treated with amphetamine or derivatives of
amphetamine.
 Pharmacokinetic
• Amphetamine is completely absorbed from the gastrointestinal
tract, metabolized by the liver, and excreted in the urine.
• Amphetamine abusers often administer the drugs by IV injection
and by smoking.
• The euphoria caused by amphetamine lasts 4 to 6 hours, or four-
to eight-fold longer than the effects of cocaine.
HALLUCINOGENS
Psychotomimetic drugs, that induce
altered perceptual states
accompanied by visions of bright,
colorful changes in the environment.
These drugs impair normal decision-
making because they interfere with
rational thought.
HALLUCINOGENS
 Lysergic acid diethylamide (LSD)
• Serotonin agonist.
• Activation of the sympathetic nervous system
occurs causing pupillary dilation, increased
blood pressure, and increased body
temperature.
• Taken orally, low doses of LSD can induce
hallucinations with brilliant colors.
• Haloperidol and other neuroleptics can block
the hallucinatory action of LSD.
 Adverse effects
• Hyperreflexia, nausea, and muscular weakness.
• High doses may produce long-lasting psychotic
changes.
HALLUCINOGENS
• Tetrahydrocannabinol
• Found in marijuana
• Produce euphoria followed by
drowsiness and relaxation
• This product is prescribed to treat
emesis and to stimulate the appetite.
• Its wide range of effects includes
appetite stimulation, xerostomia, visual
hallucinations, delusions, and
enhancement of sensory activity.
Tetrahydrocannabinol
 Adverse effects include:-
• increased heart rate
• decreased blood pressure
• reddening of the
conjunctiva.
At high doses, a toxic psychosis
develops.
HALLUCINOGENS
Phencyclidine
• Illegal drug.
• Also known as PCP or angel’s dust.
• Inhibits the reuptake of dopamine, 5-HT, NE.
• Produces numbness of extremities, staggered gait,
slurred speech, and muscular rigidity.
• At increased dosages, anesthesia, stupor and coma
may result.
• Increased sensitivity to external stimuli results, CNS
actions may persist for a week.
• Tolerance often develops with continued use.
• No therapeutic applications.
Cognition Enhancers
(cerebroactive drugs)
What is
cognition?
• In simple terms it is the Brain process of acquiring and exploiting
knowledge.
• Mental processes involved in gaining knowledge and
comprehension, including thinking, knowing, remembering,
judging and problem-solving
– higher-level functions of the brain and encompass language,
imagination, perception and planning
Multiple levels of Neurobiological process –
learning, memory, attention and motivation
Hippocampus– encoding new information
Strio-frontal circuit– decision making
Frontal lobe - retrieval
• Cognition Enhancers are the drugs used in the disorders of these
functions
– Amnesia Alzheimer`s Disease
What is Dementia?
 Deterioration of intellectual faculties, such as memory, concentration,
and judgment to previously unimpaired person.
Lost: Memory, capacity to solve problems of day to day, learned motor
skills, social skills, control of emotions.
Retained: Consciousness and motor functions.
 Causes:
o Aging
o Alzheimer`s Disease
 Most common cause of dementia.
 Progressive neurodegenerative disorder of older
individuals leading to a total vegetative state.
 Atrophy of cortical and subcortical areas with
deposition of amyloid protein in the form of senile
plaques - marked cholinergic deficiency.
o TIA, CVA and stroke etc.
Classification
Cholinergic
activators
Tacrine,
Rivastigmine,
Donepezil,
Galantamine
Glutamate (NMDA)
antagonist: Memantine
Miscellaneous
Piracetam,
Pyritinol,
Dihydroergotoxi
ne, Piribedil,
Ginko biloba
Herbs and
Nutrients
How do they
work?
– They are believed to act by:
Increasing Blood Flow
Increased Brain
 Neurotransmission Enhancement
 Increased Neuronal metabolism
 Stimulation of Hormones and
Enzymes
 Increased Nerve growth
– Improvement of Cerebral Functions -
Memory
Ginko biloba
• – Ginko meaning naked
• – Maidenhair Tree - Chinese and Japanese plant
• – Contains ginkgoflavon glycosides – PAF antagonist
• – Used in a variety of cognitive and behavioural disorders in Elderly
• – Prevents cerebral impairment in Multiple infarct disease (MID)
• – ADRs: GIT upset and arrhythmia etc.
• – Doses: 40 mg tds for 4 weeks
• – Preparations: Ginkocer, Bilovas, Ginkoba
• – Efficacy is doubtful – also used with Gotu Kola (Brahmi)
Cns stimulants

More Related Content

What's hot

Antipsychotics - drdhriti
Antipsychotics - drdhritiAntipsychotics - drdhriti
Antipsychotics - drdhriti
http://neigrihms.gov.in/
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
Dr. Pooja
 
Antipsychotics and updates
Antipsychotics and updatesAntipsychotics and updates
Antipsychotics and updates
Jyoti Sharma
 
ANTI DEPRESSANT DRUGS / DRUG USED IN THE TREATMENT OF DEPRESSION / ANTI DEPRE...
ANTI DEPRESSANT DRUGS / DRUG USED IN THE TREATMENT OF DEPRESSION / ANTI DEPRE...ANTI DEPRESSANT DRUGS / DRUG USED IN THE TREATMENT OF DEPRESSION / ANTI DEPRE...
ANTI DEPRESSANT DRUGS / DRUG USED IN THE TREATMENT OF DEPRESSION / ANTI DEPRE...
Kameshwaran Sugavanam
 
Sympathomimetic System- Pharmacology
Sympathomimetic System- PharmacologySympathomimetic System- Pharmacology
Sympathomimetic System- Pharmacology
AdarshPatel73
 
Drug therapy of depression
Drug therapy of depression Drug therapy of depression
Drug therapy of depression
Dr Htet
 
Dopamine
DopamineDopamine
Dopamine
Sethu S
 
anti-psychotic drugs
anti-psychotic drugsanti-psychotic drugs
anti-psychotic drugs
DJ CrissCross
 
Cns stimulant final ppt july 2021
Cns stimulant final ppt  july 2021Cns stimulant final ppt  july 2021
Cns stimulant final ppt july 2021
muthulakshmi623285
 
Antianxiety agents
Antianxiety agentsAntianxiety agents
Antianxiety agents
DR.SOUMITRA DAS
 
Sedatives & hypnotics
Sedatives & hypnoticsSedatives & hypnotics
Sedatives & hypnotics
Dr Resu Neha Reddy
 
Cns stimulants by Dr. Nadeem Korai
Cns stimulants by Dr. Nadeem KoraiCns stimulants by Dr. Nadeem Korai
Cns stimulants by Dr. Nadeem KoraiNadeemkorai
 
Cns stimulants & cognition enhancers
Cns stimulants & cognition enhancersCns stimulants & cognition enhancers
Cns stimulants & cognition enhancers
Rudhra Prabhakar
 
CNS stimulants & cognitive enhancers
CNS stimulants & cognitive enhancersCNS stimulants & cognitive enhancers
CNS stimulants & cognitive enhancers
Dr.UMER SUFYAN M
 
Antipsychotic drug
Antipsychotic drug Antipsychotic drug
Antipsychotic drug
Vibha Manu
 
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.DCNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
Kameshwaran Sugavanam
 
Anxiolytics and Sedative/ Hypnotics (Full Lect.)
Anxiolytics and Sedative/ Hypnotics (Full Lect.)Anxiolytics and Sedative/ Hypnotics (Full Lect.)
Anxiolytics and Sedative/ Hypnotics (Full Lect.)
Sawsan Aboul-Fotouh
 
Antiparkinson's Drugs
Antiparkinson's DrugsAntiparkinson's Drugs
Antiparkinson's Drugs
Bhudev Global
 
Antidepressants
Antidepressants Antidepressants
Antidepressants
http://neigrihms.gov.in/
 

What's hot (20)

Antipsychotics - drdhriti
Antipsychotics - drdhritiAntipsychotics - drdhriti
Antipsychotics - drdhriti
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
 
Antipsychotics and updates
Antipsychotics and updatesAntipsychotics and updates
Antipsychotics and updates
 
ANTI DEPRESSANT DRUGS / DRUG USED IN THE TREATMENT OF DEPRESSION / ANTI DEPRE...
ANTI DEPRESSANT DRUGS / DRUG USED IN THE TREATMENT OF DEPRESSION / ANTI DEPRE...ANTI DEPRESSANT DRUGS / DRUG USED IN THE TREATMENT OF DEPRESSION / ANTI DEPRE...
ANTI DEPRESSANT DRUGS / DRUG USED IN THE TREATMENT OF DEPRESSION / ANTI DEPRE...
 
Sympathomimetic System- Pharmacology
Sympathomimetic System- PharmacologySympathomimetic System- Pharmacology
Sympathomimetic System- Pharmacology
 
Drug therapy of depression
Drug therapy of depression Drug therapy of depression
Drug therapy of depression
 
Dopamine
DopamineDopamine
Dopamine
 
anti-psychotic drugs
anti-psychotic drugsanti-psychotic drugs
anti-psychotic drugs
 
Cns stimulant final ppt july 2021
Cns stimulant final ppt  july 2021Cns stimulant final ppt  july 2021
Cns stimulant final ppt july 2021
 
Antipsychotics
AntipsychoticsAntipsychotics
Antipsychotics
 
Antianxiety agents
Antianxiety agentsAntianxiety agents
Antianxiety agents
 
Sedatives & hypnotics
Sedatives & hypnoticsSedatives & hypnotics
Sedatives & hypnotics
 
Cns stimulants by Dr. Nadeem Korai
Cns stimulants by Dr. Nadeem KoraiCns stimulants by Dr. Nadeem Korai
Cns stimulants by Dr. Nadeem Korai
 
Cns stimulants & cognition enhancers
Cns stimulants & cognition enhancersCns stimulants & cognition enhancers
Cns stimulants & cognition enhancers
 
CNS stimulants & cognitive enhancers
CNS stimulants & cognitive enhancersCNS stimulants & cognitive enhancers
CNS stimulants & cognitive enhancers
 
Antipsychotic drug
Antipsychotic drug Antipsychotic drug
Antipsychotic drug
 
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.DCNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
CNS STIMULANTS & NOOTROPICS (COGNITION ENHANCERS) for B.Pharm & Pharm.D
 
Anxiolytics and Sedative/ Hypnotics (Full Lect.)
Anxiolytics and Sedative/ Hypnotics (Full Lect.)Anxiolytics and Sedative/ Hypnotics (Full Lect.)
Anxiolytics and Sedative/ Hypnotics (Full Lect.)
 
Antiparkinson's Drugs
Antiparkinson's DrugsAntiparkinson's Drugs
Antiparkinson's Drugs
 
Antidepressants
Antidepressants Antidepressants
Antidepressants
 

Similar to Cns stimulants

cnsstimulants.pptx
cnsstimulants.pptxcnsstimulants.pptx
cnsstimulants.pptx
Aymanshahzad4
 
6 Pharmacology I CNS Stimulants NK, trimmed.pptx
6 Pharmacology I CNS Stimulants NK, trimmed.pptx6 Pharmacology I CNS Stimulants NK, trimmed.pptx
6 Pharmacology I CNS Stimulants NK, trimmed.pptx
Ahmad Kharousheh
 
CNS Stimulants.pptx
CNS Stimulants.pptxCNS Stimulants.pptx
CNS Stimulants.pptx
Aymanshahzad4
 
CNS stimulants - Parmacology
CNS stimulants - ParmacologyCNS stimulants - Parmacology
CNS stimulants - Parmacology
Areej Abu Hanieh
 
2-CNS-stimulant.ppt
2-CNS-stimulant.ppt2-CNS-stimulant.ppt
2-CNS-stimulant.ppt
Khadiza8
 
8QuyYhigEyF50OSLZMog.pdf
8QuyYhigEyF50OSLZMog.pdf8QuyYhigEyF50OSLZMog.pdf
8QuyYhigEyF50OSLZMog.pdf
Imtiyaz60
 
Psychomotor stimulant
Psychomotor stimulantPsychomotor stimulant
Psychomotor stimulant
Umangi Chauhan
 
cns stimulants and drug abuse.pdf
cns stimulants and drug abuse.pdfcns stimulants and drug abuse.pdf
cns stimulants and drug abuse.pdf
Vijay Salvekar
 
PHAR 4472 CNS Stimulants abuse & toxicity.ppt
PHAR 4472 CNS Stimulants abuse & toxicity.pptPHAR 4472 CNS Stimulants abuse & toxicity.ppt
PHAR 4472 CNS Stimulants abuse & toxicity.ppt
PrabaNanthan
 
CNS-stimulants.pptx
CNS-stimulants.pptxCNS-stimulants.pptx
CNS-stimulants.pptx
AhmadShafiq43
 
CNS-stimulants.pdf
CNS-stimulants.pdfCNS-stimulants.pdf
CNS-stimulants.pdf
Imtiyaz60
 
Drugs of abuse - Pharmacology
Drugs of abuse - PharmacologyDrugs of abuse - Pharmacology
Drugs of abuse - Pharmacology
Areej Abu Hanieh
 
Pharmacological actions of CNS Stimulants
Pharmacological actions of CNS StimulantsPharmacological actions of CNS Stimulants
Pharmacological actions of CNS Stimulants
Sreenivasa Reddy Thalla
 
Tobacco Addiction
Tobacco AddictionTobacco Addiction
Tobacco Addiction
Abinayaa Arasu
 
Cns stimulant by yogesh sangle
Cns stimulant by yogesh sangleCns stimulant by yogesh sangle
Cns stimulant by yogesh sangle
Ashish Agrawal
 
stimulants
stimulantsstimulants
stimulants
Ikenna Godwin
 
antidepressants-tcassri-090907232222-phpapp02.pptx
antidepressants-tcassri-090907232222-phpapp02.pptxantidepressants-tcassri-090907232222-phpapp02.pptx
antidepressants-tcassri-090907232222-phpapp02.pptx
HungryHostellite
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulantsraj kumar
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulantsraj kumar
 

Similar to Cns stimulants (20)

cnsstimulants.pptx
cnsstimulants.pptxcnsstimulants.pptx
cnsstimulants.pptx
 
6 Pharmacology I CNS Stimulants NK, trimmed.pptx
6 Pharmacology I CNS Stimulants NK, trimmed.pptx6 Pharmacology I CNS Stimulants NK, trimmed.pptx
6 Pharmacology I CNS Stimulants NK, trimmed.pptx
 
CNS Stimulants.pptx
CNS Stimulants.pptxCNS Stimulants.pptx
CNS Stimulants.pptx
 
CNS stimulants - Parmacology
CNS stimulants - ParmacologyCNS stimulants - Parmacology
CNS stimulants - Parmacology
 
2-CNS-stimulant.ppt
2-CNS-stimulant.ppt2-CNS-stimulant.ppt
2-CNS-stimulant.ppt
 
8QuyYhigEyF50OSLZMog.pdf
8QuyYhigEyF50OSLZMog.pdf8QuyYhigEyF50OSLZMog.pdf
8QuyYhigEyF50OSLZMog.pdf
 
Psychomotor stimulant
Psychomotor stimulantPsychomotor stimulant
Psychomotor stimulant
 
cns stimulants and drug abuse.pdf
cns stimulants and drug abuse.pdfcns stimulants and drug abuse.pdf
cns stimulants and drug abuse.pdf
 
PHAR 4472 CNS Stimulants abuse & toxicity.ppt
PHAR 4472 CNS Stimulants abuse & toxicity.pptPHAR 4472 CNS Stimulants abuse & toxicity.ppt
PHAR 4472 CNS Stimulants abuse & toxicity.ppt
 
CNS-stimulants.pptx
CNS-stimulants.pptxCNS-stimulants.pptx
CNS-stimulants.pptx
 
Stimulants
StimulantsStimulants
Stimulants
 
CNS-stimulants.pdf
CNS-stimulants.pdfCNS-stimulants.pdf
CNS-stimulants.pdf
 
Drugs of abuse - Pharmacology
Drugs of abuse - PharmacologyDrugs of abuse - Pharmacology
Drugs of abuse - Pharmacology
 
Pharmacological actions of CNS Stimulants
Pharmacological actions of CNS StimulantsPharmacological actions of CNS Stimulants
Pharmacological actions of CNS Stimulants
 
Tobacco Addiction
Tobacco AddictionTobacco Addiction
Tobacco Addiction
 
Cns stimulant by yogesh sangle
Cns stimulant by yogesh sangleCns stimulant by yogesh sangle
Cns stimulant by yogesh sangle
 
stimulants
stimulantsstimulants
stimulants
 
antidepressants-tcassri-090907232222-phpapp02.pptx
antidepressants-tcassri-090907232222-phpapp02.pptxantidepressants-tcassri-090907232222-phpapp02.pptx
antidepressants-tcassri-090907232222-phpapp02.pptx
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
 
Cns stimulants
Cns stimulantsCns stimulants
Cns stimulants
 

More from vikasaagrahari007

PLATELET ACTIVATING FACTORS: MECHANISM OF ACTION AND CLINICAL USES
PLATELET ACTIVATING FACTORS: MECHANISM OF ACTION AND CLINICAL USESPLATELET ACTIVATING FACTORS: MECHANISM OF ACTION AND CLINICAL USES
PLATELET ACTIVATING FACTORS: MECHANISM OF ACTION AND CLINICAL USES
vikasaagrahari007
 
Patient compliance
Patient compliancePatient compliance
Patient compliance
vikasaagrahari007
 
Patients councelling
Patients councellingPatients councelling
Patients councelling
vikasaagrahari007
 
Professional relations and practices of hospital pharmacis
Professional relations and practices of hospital pharmacisProfessional relations and practices of hospital pharmacis
Professional relations and practices of hospital pharmacis
vikasaagrahari007
 
PHARMACOKINETIC MODEL
PHARMACOKINETIC MODELPHARMACOKINETIC MODEL
PHARMACOKINETIC MODEL
vikasaagrahari007
 
pathophysiology of myocardial infraction
pathophysiology of myocardial infractionpathophysiology of myocardial infraction
pathophysiology of myocardial infraction
vikasaagrahari007
 
Psoriasis
PsoriasisPsoriasis
Impetigo
ImpetigoImpetigo
pathophysiology of myocardial infarction
pathophysiology of myocardial infarctionpathophysiology of myocardial infarction
pathophysiology of myocardial infarction
vikasaagrahari007
 
Types of clinical study designs
Types of clinical study designsTypes of clinical study designs
Types of clinical study designs
vikasaagrahari007
 
observational analytical and interventional studies
observational analytical and interventional studiesobservational analytical and interventional studies
observational analytical and interventional studies
vikasaagrahari007
 
SMOKING
SMOKINGSMOKING

More from vikasaagrahari007 (12)

PLATELET ACTIVATING FACTORS: MECHANISM OF ACTION AND CLINICAL USES
PLATELET ACTIVATING FACTORS: MECHANISM OF ACTION AND CLINICAL USESPLATELET ACTIVATING FACTORS: MECHANISM OF ACTION AND CLINICAL USES
PLATELET ACTIVATING FACTORS: MECHANISM OF ACTION AND CLINICAL USES
 
Patient compliance
Patient compliancePatient compliance
Patient compliance
 
Patients councelling
Patients councellingPatients councelling
Patients councelling
 
Professional relations and practices of hospital pharmacis
Professional relations and practices of hospital pharmacisProfessional relations and practices of hospital pharmacis
Professional relations and practices of hospital pharmacis
 
PHARMACOKINETIC MODEL
PHARMACOKINETIC MODELPHARMACOKINETIC MODEL
PHARMACOKINETIC MODEL
 
pathophysiology of myocardial infraction
pathophysiology of myocardial infractionpathophysiology of myocardial infraction
pathophysiology of myocardial infraction
 
Psoriasis
PsoriasisPsoriasis
Psoriasis
 
Impetigo
ImpetigoImpetigo
Impetigo
 
pathophysiology of myocardial infarction
pathophysiology of myocardial infarctionpathophysiology of myocardial infarction
pathophysiology of myocardial infarction
 
Types of clinical study designs
Types of clinical study designsTypes of clinical study designs
Types of clinical study designs
 
observational analytical and interventional studies
observational analytical and interventional studiesobservational analytical and interventional studies
observational analytical and interventional studies
 
SMOKING
SMOKINGSMOKING
SMOKING
 

Recently uploaded

BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 

Cns stimulants

  • 2. CNS Stimulants • Two groups of drugs that act primarily to stimulate the central nervous system (CNS).  Psychomotor stimulants ◦ Cause excitement and euphoria. ◦ Decrease feeling of fatigue. ◦ Increase motor activity.  Hallucinogens (psychotomimetic drugs) ◦ Produce changes in thought patterns and mood.
  • 3. • ◦ Amphetamine • ◦ Dextroamphetamine • ◦ Methylphenidate • ◦ Caffeine • ◦ Methylxanthines • ◦ Nicotine • ◦ Cocaine Psychomotor stimulants • ◦ Lysergic acid diethylamide (LSD) • ◦ Tetrahydrocannabinol • ◦ Phencyclidine Hallucinogens
  • 4. Cocaine • Cocaine is a widely available and highly addictive drug that is currently abused daily by more than 3 million people in the US.  MOA: • Causes blocking of reuptake of monoamines neurotransmitters. So, prolongs their action.  Actions: • CNS: The behavioral effects of cocaine result from powerful stimulation of the cortex and brainstem. Increases mental awareness and produces a feeling of well- being and euphoria. Produce hallucinations and delusions of paranoia Respiratory and vasomotor depression. • Sympathetic nervous system: cocaine potentiates the action of norepinephrine. • Hyperthermia.
  • 5. Cocaine Uses • Cocaine has a local anesthetic action. For example, cocaine is applied topically as a local anesthetic during eye, ear, nose, and throat surgery. [Note: Cocaine is the only local anesthetic that causes vasoconstriction.]  Pharmacokinetic • Self-administered by chewing, intranasal snorting, smoking, or intravenous (IV) injection. The peak effect occurs at 15 to 20 minutes after intranasal intake of cocaine powder. • Because the onset of action is most rapid, the potential for overdosage and dependence is greatest with IV injection and crack smoking. • Cocaine is rapidly de-esterified and demethylated to benzoylecgonine, which is excreted in the urine. Detection of this substance in the urine identifies a user.
  • 6. Cocaine  Adverse effects: • Anxiety • Depression • Toxic effects: Cocaine can induce seizures as well as fatal cardiac arrhythmias.
  • 7. Methylxanthines Include theophylline (tea); theobromine (cocoa); and caffeine (coffee, tea, cocoa, chocolates, cola drinks). Mechanism of action. • Translocation of extracellular calcium. • Increase in cAMP and cGMP caused by inhibition of phosphodiesterase. • Blockade of adenosine receptors.
  • 8. Methylxanthines Actions  CNS- • Reduces fatigue ad increase mental alertness due to stimulation of the cortex and other areas of the brain. • At very high doses, can produce anxiety and tremor. • Tolerance to caffeine can develop and withdrawal consists of feelings of fatigue and sedation.  Cardiovascular system: • At high doses, has positive inotropic and chronotropic effects, can be harmful to angina patients and can trigger premature ventricular contractions.  Diuretic action: • Caffeine has a mild diuretic effect increasing urinary output of Na, K, and Cl.  Gastric mucosa: • Stimulate secretion of hydrochloric acid from gastric mucosa, should be avoided in peptic ulcer.
  • 9. Methylxanthines Therapeutic uses • All methylxanthines relax the smooth muscles and Causes relaxation of bronchioles so use in supportive treatment of Asthma. Adverse effects • Low dose causes insomnia, anxiety, and agitation. • A high dosage is required for toxicity, which is manifested by emesis and convulsions. • The lethal dose is about 10 g of caffeine (about 100 cups of coffee), which induces cardiac arrhythmias; death from caffeine is thus highly unlikely.
  • 10. Nicotine  Nicotine is the active ingredient in tobacco. Although this drug is not currently used therapeutically (except in smoking cessation therapy), nicotine remains important because it is second only to caffeine as the most widely used CNS stimulant, and it is second only to alcohol as the most abused drug. In combination with the tars and carbon monoxide found in cigarette smoke, nicotine represents a serious risk factor for lung and cardiovascular disease, various cancers, and other illnesses. Dependency on the drug is not easily overcome. Mechanism of action: • In low doses, nicotine causes ganglionic stimulation by depolarization. At high doses, nicotine causes ganglionic blockade. Nicotine receptors exist at a number of sites in the CNS, which participate in the stimulant attributes of the drug.
  • 11. Nicotine CNS stimulant. Stimulation of sympathetic ganglia increases blood pressure and heart rate. Particularly harmful in hypertensive patients. Nicotine induced vasoconstriction can decrease coronary blood flow, adversely affecting a patient with angina. High doses of nicotine result in central respiratory paralysis and severe hypotension caused by medullary paralysis. Along with other components of cigarettes like tars and carbon monoxide, nicotine is a risk factor for lung and cardiovascular diseases and cancer.
  • 12. Nicotine Causes dependence that is not easily overcome Withdrawal symptoms include irritability, anxiety, restlessness, headaches and insomnia Smoking cessation programs should combine pharmacologic and behavioral therapy Transdermal nicotine patch and nicotine chewing gum can reduce withdrawal symptoms Bupropion (Wellbutrin®, Zyban®) Antidepressant, can reduce the craving for cigarettes
  • 13. Nicotine • Because nicotine is highly lipid soluble, absorption readily occurs • Nicotine crosses the placental membrane and is secreted in the milk of lactating women. • The acute lethal dose is 60 mg. More than 90 percent of the nicotine inhaled in smoke is absorbed. • Clearance of nicotine involves metabolism in the lung and the liver and urinary excretion. Pharmacokinetic • Irritability and tremors, intestinal cramps, diarrhea, and increased heart rate and blood pressure. • In addition, cigarette smoking increases the rate of metabolism for a number of drugs Adverse effects
  • 14. Amphetamine  Amphetamine is a non catecholaminergic sympathetic amine. Dextroamphetamine is the major member of this class of compounds. Methamphetamine is a derivative of amphetamine that can be smoked, and it is preferred by many abusers.  MOA • Releasing intracellular stores of catecholamines. • Because amphetamine also inhibits monoamine oxidase (MAO), high levels of catecholamines are readily released into synaptic spaces.  Action  CNS: Stimulates the entire cerebrospinal axis, cortex, brainstem, and medulla. This leads to increased alertness, decreased fatigue, depressed appetite, and insomnia.  Sympathetic nervous system: Amphetamine acts on the adrenergic system, indirectly stimulating the receptors through norepinephrine release.
  • 15. Amphetamine  Uses • Attention deficit hyperactivity disorder (ADHD): Some young children are hyperkinetic and lack the ability to be involved in any one activity for longer than a few minutes. Dextroamphetamine and Methamphetamine are able to improve attention and to alleviate many of the behavioral problems associated with this syndrome • Narcolepsy: [Narcolepsy is a relatively rare sleep disorder that is characterized by uncontrollable bouts of sleepiness during the day]. It is sometimes accompanied by catalepsy, a loss in muscle control, or even paralysis brought on by strong emotions, such as laughter. However, it is the sleepiness for which the patient is usually treated with amphetamine or derivatives of amphetamine.  Pharmacokinetic • Amphetamine is completely absorbed from the gastrointestinal tract, metabolized by the liver, and excreted in the urine. • Amphetamine abusers often administer the drugs by IV injection and by smoking. • The euphoria caused by amphetamine lasts 4 to 6 hours, or four- to eight-fold longer than the effects of cocaine.
  • 16.
  • 17. HALLUCINOGENS Psychotomimetic drugs, that induce altered perceptual states accompanied by visions of bright, colorful changes in the environment. These drugs impair normal decision- making because they interfere with rational thought.
  • 18. HALLUCINOGENS  Lysergic acid diethylamide (LSD) • Serotonin agonist. • Activation of the sympathetic nervous system occurs causing pupillary dilation, increased blood pressure, and increased body temperature. • Taken orally, low doses of LSD can induce hallucinations with brilliant colors. • Haloperidol and other neuroleptics can block the hallucinatory action of LSD.  Adverse effects • Hyperreflexia, nausea, and muscular weakness. • High doses may produce long-lasting psychotic changes.
  • 19. HALLUCINOGENS • Tetrahydrocannabinol • Found in marijuana • Produce euphoria followed by drowsiness and relaxation • This product is prescribed to treat emesis and to stimulate the appetite. • Its wide range of effects includes appetite stimulation, xerostomia, visual hallucinations, delusions, and enhancement of sensory activity.
  • 20. Tetrahydrocannabinol  Adverse effects include:- • increased heart rate • decreased blood pressure • reddening of the conjunctiva. At high doses, a toxic psychosis develops.
  • 21. HALLUCINOGENS Phencyclidine • Illegal drug. • Also known as PCP or angel’s dust. • Inhibits the reuptake of dopamine, 5-HT, NE. • Produces numbness of extremities, staggered gait, slurred speech, and muscular rigidity. • At increased dosages, anesthesia, stupor and coma may result. • Increased sensitivity to external stimuli results, CNS actions may persist for a week. • Tolerance often develops with continued use. • No therapeutic applications.
  • 23. What is cognition? • In simple terms it is the Brain process of acquiring and exploiting knowledge. • Mental processes involved in gaining knowledge and comprehension, including thinking, knowing, remembering, judging and problem-solving – higher-level functions of the brain and encompass language, imagination, perception and planning Multiple levels of Neurobiological process – learning, memory, attention and motivation Hippocampus– encoding new information Strio-frontal circuit– decision making Frontal lobe - retrieval • Cognition Enhancers are the drugs used in the disorders of these functions – Amnesia Alzheimer`s Disease
  • 24. What is Dementia?  Deterioration of intellectual faculties, such as memory, concentration, and judgment to previously unimpaired person. Lost: Memory, capacity to solve problems of day to day, learned motor skills, social skills, control of emotions. Retained: Consciousness and motor functions.  Causes: o Aging o Alzheimer`s Disease  Most common cause of dementia.  Progressive neurodegenerative disorder of older individuals leading to a total vegetative state.  Atrophy of cortical and subcortical areas with deposition of amyloid protein in the form of senile plaques - marked cholinergic deficiency. o TIA, CVA and stroke etc.
  • 26. How do they work? – They are believed to act by: Increasing Blood Flow Increased Brain  Neurotransmission Enhancement  Increased Neuronal metabolism  Stimulation of Hormones and Enzymes  Increased Nerve growth – Improvement of Cerebral Functions - Memory
  • 27. Ginko biloba • – Ginko meaning naked • – Maidenhair Tree - Chinese and Japanese plant • – Contains ginkgoflavon glycosides – PAF antagonist • – Used in a variety of cognitive and behavioural disorders in Elderly • – Prevents cerebral impairment in Multiple infarct disease (MID) • – ADRs: GIT upset and arrhythmia etc. • – Doses: 40 mg tds for 4 weeks • – Preparations: Ginkocer, Bilovas, Ginkoba • – Efficacy is doubtful – also used with Gotu Kola (Brahmi)